A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

1. Mirza, M.R.
2. González-Martín, A.
3. Graybill, W.S.
4. O'Malley, D.M.
5. Gaba, L.
6. Stephanie Yap, O.W.
7. Guerra, E.M.
8. Rose, P.G.
9. Baurain, J.-F.
10. Ghamande, S.A.
11. Denys, H.
12. Prendergast, E.
13. Pisano, C.
14. Follana, P.
15. Baumann, K.
16. Calvert, P.M.
17. Korach, J.
18. Li, Y.
19. Malinowska, I.A.
20. Gupta, D.
21. Monk, B.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.2217/FON-2023-0755 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus